SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-15-009542
Filing Date
2015-08-19
Accepted
2015-08-18 21:44:53
Documents
16

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1909740
2 filename2.htm EX-2 401157
3 filename3.htm EX-3 111090
4 filename4.htm EX-3 106907
5 filename5.htm EX-4 252936
6 filename6.htm EX-10 400989
7 filename7.htm EX-10 211183
8 filename8.htm EX-21 1509
9 GRAPHIC g23325g22d56.jpg GRAPHIC 25156
10 GRAPHIC g23325g26a74.jpg GRAPHIC 58484
11 GRAPHIC g23325g92h88.jpg GRAPHIC 27889
12 GRAPHIC g34799g21w13.jpg GRAPHIC 6228
13 GRAPHIC g34799g58r86.jpg GRAPHIC 60477
14 GRAPHIC g34799image002.jpg GRAPHIC 172822
15 GRAPHIC g34799image003.jpg GRAPHIC 37187
16 GRAPHIC g34799image005.jpg GRAPHIC 53946
  Complete submission text file 0000950123-15-009542.txt   4006033
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-01116 | Film No.: 151062790
SIC: 2834 Pharmaceutical Preparations